- Home
- ARBK vs IMAB Comparison
ARBK vs IMAB Comparison
Compare ARBK & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBK
- IMAB
- Stock Information
- Founded
- ARBK 2017
- IMAB 2014
- Country
- ARBK United Kingdom
- IMAB United States
- Employees
- ARBK N/A
- IMAB N/A
- Industry
- ARBK Finance: Consumer Services
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- ARBK Finance
- IMAB Health Care
- Exchange
- ARBK Nasdaq
- IMAB Nasdaq
- Market Cap
- ARBK 75.1M
- IMAB 83.8M
- IPO Year
- ARBK 2021
- IMAB 2020
- Fundamental
- Price
- ARBK $1.25
- IMAB $1.06
- Analyst Decision
- ARBK Hold
- IMAB Strong Buy
- Analyst Count
- ARBK 2
- IMAB 3
- Target Price
- ARBK $1.45
- IMAB $8.00
- AVG Volume (30 Days)
- ARBK 1.1M
- IMAB 410.6K
- Earning Date
- ARBK 11-19-2024
- IMAB 08-28-2024
- Dividend Yield
- ARBK N/A
- IMAB N/A
- EPS Growth
- ARBK N/A
- IMAB N/A
- EPS
- ARBK N/A
- IMAB N/A
- Revenue
- ARBK $55,817,000.00
- IMAB $3,492,091.00
- Revenue This Year
- ARBK N/A
- IMAB N/A
- Revenue Next Year
- ARBK $175.58
- IMAB N/A
- P/E Ratio
- ARBK N/A
- IMAB N/A
- Revenue Growth
- ARBK 16.44
- IMAB N/A
- 52 Week Low
- ARBK $1.04
- IMAB $0.99
- 52 Week High
- ARBK $4.45
- IMAB $2.54
- Technical
- Relative Strength Index (RSI)
- ARBK 55.95
- IMAB 40.43
- Support Level
- ARBK $1.09
- IMAB $1.02
- Resistance Level
- ARBK $1.37
- IMAB $1.12
- Average True Range (ATR)
- ARBK 0.14
- IMAB 0.08
- MACD
- ARBK 0.01
- IMAB -0.01
- Stochastic Oscillator
- ARBK 52.75
- IMAB 20.00
About ARBK Argo Blockchain plc
Argo Blockchain PLC is a data center business that provides a powerful and efficient platform for cryptocurrency mining operations. The company has operations in strategic locations in North America.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).